Move Enhances AAHI's Capacity to Advance Vaccine Innovations for Global Health Challenges

The Access to Advanced Health Institute (AAHI), a nonprofit biotech research institute dedicated to developing accessible, cost-effective vaccines against deadly diseases such as tuberculosis, malaria, and HIV, today announced its relocation to state-of-the-art serviced labs at CoLabs within the 222 Fifth life sciences building. This strategic move positions AAHI in a dynamic incubator environment designed to foster biotech innovation, enabling the organization to accelerate its mission of making high-impact science accessible to everyone.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903306893/en/

The new facility at 222 Fifth Avenue North in Seattle's vibrant South Lake Union district offers flexible, move-in-ready lab spaces equipped with advanced infrastructure tailored for life sciences research. As part of the CoLabs Incubator Program, AAHI joins a community of biotech innovators, benefiting from collaborative opportunities, shared resources, and proximity to Seattle's thriving biotech ecosystem.

"222 Fifth Welcomes Biotech Innovators to its CoLabs Incubator Program," said representatives from Lincoln Property Company and Intercontinental Real Estate Corporation, the developers behind the building. This program provides emerging and established biotech organizations with the tools and environment needed to thrive, including Class A laboratory spaces and support for rapid scaling.

"This relocation comes at a pivotal time for AAHI as we continue to pioneer vaccine development," said Keeley Foley, CEO of AAHI. "The move to CoLabs will enhance our research capabilities, allowing for expanded collaboration and faster translation of scientific breakthroughs into real-world solutions.

"We are excited about this new chapter at CoLabs, which aligns perfectly with our commitment to innovation and accessibility in global health. This cutting-edge space will empower our team to push the boundaries of vaccine development and bring life-saving technologies to those who need them most."

Keeley Foley added, "AAHI extends special thanks to Kris Washburn and Blair Stern of JLL Seattle, who provided pro bono assistance in securing this ideal new home. Their expertise in life sciences real estate and dedication to supporting nonprofit missions were instrumental in making this transition seamless. Additionally, AAHI gratefully acknowledges Global Tech Equipment for their invaluable support, Emerald Blue for their professional moving and storage services, Move NW for their professional moving services, and our key collaborators including Lincoln Property Company, Intercontinental Real Estate Corporation, and Excedr for their roles in facilitating this move and supporting the CoLabs ecosystem. AAHI highly recommends JLL Seattle, Global Tech Equipment, Emerald Blue, Move NW, CoLabs, and these partners for organizations seeking top-tier facilities, equipment solutions, relocation services, and advisory support."

For more information about AAHI and its work, visit www.aahi.org.

About Access to Advanced Health Institute (AAHI)

AAHI is a Seattle-based nonprofit biotech research institute focused on translating high-impact science into affordable, effective, and accessible vaccines. With a global footprint including operations in the United States, England, and South Africa, AAHI collaborates with partners worldwide to combat infectious diseases and improve health equity. For more information, visit https://www.aahi.org/ or contact us at https://www.aahi.org/contact/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250903306893/en/